KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Castle Biosciences (CSTL) Depreciation & Amortization (CF) (2018 - 2025)

Historic Depreciation & Amortization (CF) for Castle Biosciences (CSTL) over the last 8 years, with Q3 2025 value amounting to $3.8 million.

  • Castle Biosciences' Depreciation & Amortization (CF) rose 776.62% to $3.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $42.8 million, marking a year-over-year increase of 21786.22%. This contributed to the annual value of $16.0 million for FY2024, which is 2974.05% up from last year.
  • Per Castle Biosciences' latest filing, its Depreciation & Amortization (CF) stood at $3.8 million for Q3 2025, which was up 776.62% from $3.4 million recorded in Q2 2025.
  • In the past 5 years, Castle Biosciences' Depreciation & Amortization (CF) ranged from a high of $29.8 million in Q1 2025 and a low of $233000.0 during Q1 2021
  • Moreover, its 5-year median value for Depreciation & Amortization (CF) was $3.0 million (2023), whereas its average is $4.2 million.
  • Per our database at Business Quant, Castle Biosciences' Depreciation & Amortization (CF) skyrocketed by 82317.6% in 2022 and then skyrocketed by 197.13% in 2025.
  • Castle Biosciences' Depreciation & Amortization (CF) (Quarter) stood at $1.5 million in 2021, then skyrocketed by 95.8% to $2.8 million in 2022, then rose by 13.48% to $3.2 million in 2023, then surged by 78.91% to $5.8 million in 2024, then tumbled by 33.84% to $3.8 million in 2025.
  • Its Depreciation & Amortization (CF) stands at $3.8 million for Q3 2025, versus $3.4 million for Q2 2025 and $29.8 million for Q1 2025.